Premium
Chromoblastomycosis: clinical experience and review of literature
Author(s) -
Queiróz Amadeu J. R.,
Pereira Domingos Fernanda,
Antônio João R.
Publication year - 2018
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/ijd.14185
Subject(s) - chromoblastomycosis , medicine , dermatology , itraconazole , prednisone , mycosis , epidemiology , surgery , pathology , antifungal
Abstract Background Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology. Methods Series of cases of chromoblastomycosis attended in a dermatology reference service. Through an integrated system search of assistance, based on CID‐10 B43, we reviewed epidemiological and comorbidities data, clinical presentations, treatments, and outcomes of each clinical case. Results From 2011 to 2017, we had five new cases of chromoblastomycosis. The average age was 65.6 years. All of them were men. One patient was HIV‐positive, and another patient was immunosuppressed by the use of mycophenolate mofetil and prednisone due to renal transplant. Two patients had no history of evident trauma. The time between onset of symptoms and diagnosis ranged from 7 to 600 months. Fonsecaea pedrosoi was the isolated fungi. All cases were formally confirmed. Itraconazole with or without other therapies was effective in all cases. Conclusions We report five never reported cases of chromoblastomycosis, and we review the clinical experience in diagnosis and treatment of chromoblastomycosis, an infrequent and neglected subcutaneous mycosis.